FDA Approves Zurzuvae: First Oral Medication for Postpartum Depression (PPD) Read more about FDA Approves Zurzuvae: First Oral Medication for Postpartum Depression (PPD) By Vigilare Biopharma August 8, 2023Uncategorized
Get Your Medical Devices Approved by the FDA Read more about Get Your Medical Devices Approved by the FDA By Vigilare Biopharma August 28, 2024Uncategorized
FDA Approves First Gene Therapy for Aromatic L-amino Acid Decarboxylase (AADC) Deficiency: A Landmark in Rare Disease Treatment Read more about FDA Approves First Gene Therapy for Aromatic L-amino Acid Decarboxylase (AADC) Deficiency: A Landmark in Rare Disease Treatment By Vigilare Biopharma November 15, 2024FDA